The market week ending Friday, September 25, 2026, placed domestic equities directly within what historical market cycles commonly define as the classic seasonal bottom of a midterm election year. Historically, the post-triple-witching week in September exhibits pronounced pressure, with the Dow Jones Industrial Average dropping in twenty-six of the last thirty-five occurrences for an average post-1990 decline of 1.1%. According to the Stock Trader’s Almanac, late third-quarter trading marks the deepest trough of the four-year presidential election cycle before the typical onset of the pre-election cycle sweet spot heading into October and the fourth quarter.

Against this backdrop, the S&P SmallCap 600 index faced renewed scrutiny regarding its relative performance against the broader S&P 500. While large-cap benchmarks have remained elevated on extended valuations, smaller-capitalization stocks continued suffering from a wide relative valuation discount. Data from CFRA shows the S&P SmallCap 600 trading at approximately 18.1 times forward twelve-month earnings estimates, compared to 22.9 times for the large-cap S&P 500. Year to date and over the trailing twelve months, small companies have relied on fundamentally superior projected profit growth to sustain investor interest. Consensus projections now look for the S&P SmallCap 600 to deliver 18.6% earnings growth in 2026, outpacing the 13.1% forecast for the S&P 500, a huge improvement for small companies over the uninspiring 6% advance they posted in 2025 compared to the S&P 500's 16% climb.

Macroeconomic indicators released through the period underscored persistent concerns. Stable domestic employment conditions, characterized by nonfarm payroll expansion of 172,000 and an unemployment rate resting at 4.3%, provided ballast alongside low consumer debt-service ratios of 11.1%. However, monetary policy considerations dominated investor attention as Fed Chair Kevin Warsh coped with stubborn inflation data. Persistent pricing pressures have curtailed hopes for rapid monetary easing, obliging the central bank to maintain a tightening monetary stance that tests credit-sensitive businesses.

Sector trends were varying. Healthcare and biotechnology experienced sustained merger-and-acquisition activity alongside strong stock selection, providing defensive resilience. Industrials gained momentum from infrastructure investments and operational efficiencies, while mortgage and real estate operations maintained stable transaction volumes, supported by steady demand forecasts from agricultural mortgage agencies and homebuilders. High-valuation tech stocks remained under intense scrutiny as market participants demanded real, tangible productivity returns from heavy AI infrastructure spending.

Near term, investors will be watching for drawdowns in the aftermath of September's triple-witching, monitoring midterm election campaign shenanigans, and checking for confirmation about market lows before initiating renewed buying. Over the long term, investors continue to contemplate whether the massive valuation gap between small-cap and mega-cap equities will finally narrow, positioning portfolios for potential cyclical fourth-quarter rallies into 2027 as historical midterm lows transition toward new pre-election market cycle peaks.

In the SmallCap Informer

Since the October 2026 issue was published last week, our top performers have been:

• Pro-Dex (PDEX) +16.2%
• Karat Packaging (KRT) +15.2%
• UFP Technologies (UFPT) +7.5%

Subscribe today to unlock our current best ideas for total return!

Stay the course!

— DOUG GERLACH, EDITOR-IN-CHIEF

Get great small company stock ideas in each issue of the SmallCap Informer stock newsletter. Subscribe to the SmallCap Informer and get monthly small company stock recommendations and updated buy/sell prices for each of the ~40 high-quality small company stocks currently covered in the newsletter.